Korecyte Bio

Korecyte Bio is excited to announce that we have incorporated in the UK! Korecyte Innovations Ltd will pioneer our R&D activities for next generation hypoxia-sensing #CART approaches for treating #cancer

Exciting to see our first 20 new hypoxia-sensing CAR-T constructs in viruses ready for testing. Korecyte’s R&D is underway on our mission for developing less toxic and more efficacious #CART treatments for solid #cancers

An exciting day for Korecyte Bio! We have finalised a commercial contract with @KingsCollegeLon to pursue hypoxia-sensing #CART #Immunotherapy. A technology for treating solid cancers while avoiding off-tumour activation to lower toxicities for CAR-T. kcl.ac.uk/news/kings-sig…